Clinical Studies and Protocols
Site Map Investigators Log-inClinical Studies at The Rockefeller University Hospital
Click below for more details or search for keywords above.
List of Protocols for Psoriasis and Skin Diseases
- (AHA-0517) Tissue gene responses to intradermal-gamma (IFN-gamma) in normal and psoriatic patients
- (BDA-0688) Psoriasis Inflammation and Systemic Co-Morbidities: Is it Preventable or Reversible?
- (EFU-0529) Gene expression, differentiation, and hair disorders in human skin
- (JCO-0590) Narrowband UVB in patients with vitiligo
- (JKR-0179) Screening for entry into psoriasis studies
- (JKR-0336) Use of humanized CD25 (DaclizumabTM) monoclonal
- (JKR-0337) Use of Humanized CD25 (anti-TAC) Monoclonal Antibody/Placebo to Prevent Relapse of Psoriasis Vulgaris Following NB-UVB Therapy
- (JKR-0338) A study to determine how well skin with psoriasis vulgaris improves with a specific wavelength of UVB (narrowband) light therapy in persons with dark skin tones
- (JKR-0397) Collection of blood specimens for research purposes
- (JKR-0442) A study to document the natural course and history of psoriasis before, during and after treatment with conventional therapies
- (JKR-0491) Skin biopsy for analysis of cell growth, cell differentiation and inflammation in the skin
- (JKR-0511) A Phase III study to help understand the action of the drug Efalizumab, trade name Raptiva , for the adult patient with moderate to severe plaque psoriasis and who is a candidate for internal medications
- (JKR-0542) Study to Evaluate the Effectiveness and Safety of Etanercept in the Treatment of Subjects with Psoriasis
- (JKR-0603) Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis
- (JKR-0608)A comparative study of tools used to measure the severity of psoriasis and response to therapy
- (JKR-0622) The Natural History of Pigmented Skin Lesions
- (JKR-0641) A study to document the natural history of atopic dermatitis before, during, and after treatment with conventional therapies
- (JKR-0653) Safety and Tolerability of the Investigational Medicine AbGn-168 in the Treatment of Chronic Plaque Psoriasis
- (JKR-0663) A study to evaluate reversal of the pathological epidermal phenotype in severe AD with suppression of immune activation during cyclosporine A therapy
- (JKR-0671) A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis
- (JKR-0686) Screening for Entry into Skin Disease Studies
- (KNO-0665) A pilot study investigating the effect of IL-17 on neutrophils in normal volunteers and patients with psoriasis
- (MLO-0651) UVB Phototherapy in the Treatment of Psoriasis Vulgaris
- (MPA-0677) ClyS on Psoriatic Scales
